1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Brain Tumor, Primary: new trials by email Literature Review of Brain Tumor, Primary trials Research Report on Brain Tumor, Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases | Phase 2 | Completed | Reveal Pharmaceuticals Inc. | 18 | 2024-08-15 | 2025-12-26 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Meningioma (1) · Multiple Sclerosis (1) · Neoplasms (1) · Neurilemmoma (1) · Neurofibroma (1) · Neuroinflammatory Diseases (1) · Neuroma, Acoustic (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cranial Nerve Diseases (1) · Cranial Nerve Neoplasms (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Ear Diseases (1) · Immune System Diseases (1) · Inflammation (1) · Meningeal Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1)
Mn-PyC3A (1)
Reveal Pharmaceuticals Inc. (1)
United States (1)
R44CA261240 (1)